Foramen secundum

The foramen secundum is an important structure in the developing heart of a fetus. It is part of the interatrial septum, which separates the right atrium from the left atrium. The foramen secundum plays a crucial role in fetal circulation, allowing blood to bypass the non-functioning fetal lungs.
Development[edit]
During fetal development, the septum primum forms first, creating a partial partition between the right and left atria. As the septum primum grows, it leaves a temporary opening called the ostium primum. As the septum primum continues to develop, the ostium primum closes, and a new opening, the foramen secundum, forms in the upper part of the septum primum.
The foramen secundum ensures that blood can continue to flow from the right atrium to the left atrium, bypassing the lungs, which are not yet in use. This is essential for proper fetal circulation, as the placenta is responsible for oxygenating the blood.
Closure[edit]
After birth, the foramen secundum, along with the foramen ovale, typically closes as the newborn begins to breathe air and the lungs become functional. The increased pressure in the left atrium causes the septum primum to press against the septum secundum, effectively sealing the foramen ovale and secundum. This closure forms the fossa ovalis in the adult heart.
Clinical Significance[edit]
In some cases, the foramen secundum may not close properly, leading to a condition known as a patent foramen ovale (PFO). A PFO can allow blood to flow between the atria, which may lead to complications such as stroke or migraines in some individuals.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian